97 related articles for article (PubMed ID: 17251905)
1. Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.
Di Ianni M; Moretti L; Del Papa B; De Ioanni M; Bonifacio E; Falzetti F; Tabilio A
Leukemia; 2007 Feb; 21(2):377-8. PubMed ID: 17251905
[No Abstract] [Full Text] [Related]
2. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
Wilkins BS
Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
[No Abstract] [Full Text] [Related]
3. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
Takahashi M; Fujiwara M
Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
[No Abstract] [Full Text] [Related]
4. Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.
Mercier F; Monczak Y; François M; Prchal J; Galipeau J
Exp Hematol; 2009 Mar; 37(3):416-20. PubMed ID: 19135773
[TBL] [Abstract][Full Text] [Related]
5. Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells.
Schwartz GN; Warren MK; Rothwell SW; Zujewski J; Halverson DC; Cowan KH; Tolcher A; O'Shaughnessy J; Gress RE
Bone Marrow Transplant; 1998 Sep; 22(5):457-68. PubMed ID: 9733269
[TBL] [Abstract][Full Text] [Related]
6. [Granulopoiesis in chronic myeloproliferative disorders (CMPD): electron microscopy/morphometric investigations].
Fritsch RS; Maschek H; Ehlerding C; Widjaja W; Choritz H; Georgii A
Verh Dtsch Ges Pathol; 1990; 74():216-9. PubMed ID: 1708587
[TBL] [Abstract][Full Text] [Related]
7. 8p11 Myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case report and review of the literature.
Kim SY; Oh B; She CJ; Kim HK; Jeon YK; Shin MG; Yoon SS; Lee DS
Leuk Res; 2011 May; 35(5):e30-4. PubMed ID: 21239058
[No Abstract] [Full Text] [Related]
8. Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders.
Yoon SY; Tefferi A; Li CY
Haematologica; 2001 Jan; 86(1):52-7. PubMed ID: 11146571
[TBL] [Abstract][Full Text] [Related]
9. Human bone marrow granulocyte-macrophageal colonies (GM-Cs) in vitro: myeloid cells in health and in cases of myeloid leukemia.
Zvetkova E; Savov Y; Gluhcheva Y; Ilieva I; Bichkidjieva E; Katzarova E; Tsenov I
Clin Hemorheol Microcirc; 2004; 30(3-4):481-4. PubMed ID: 15258392
[TBL] [Abstract][Full Text] [Related]
10. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
Preisler HD
Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
[No Abstract] [Full Text] [Related]
11. The pathogenesis of chronic myeloproliferative diseases.
Tefferi A
Int J Hematol; 2001 Feb; 73(2):170-6. PubMed ID: 11372728
[TBL] [Abstract][Full Text] [Related]
12. Detangling fibrosis assessment in MPNs.
Mesa RA
Leuk Res; 2010 Jul; 34(7):854-5. PubMed ID: 20137811
[No Abstract] [Full Text] [Related]
13. Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases.
Dimitriou H; Linardakis E; Martimianaki G; Stiakaki E; Perdikogianni CH; Charbord P; Kalmanti M
Cytotherapy; 2008; 10(2):125-33. PubMed ID: 18368591
[TBL] [Abstract][Full Text] [Related]
14. [Cytologic examinations in leukemia and related conditions].
Stavem P
Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2216-20. PubMed ID: 4439380
[No Abstract] [Full Text] [Related]
15. Myxomatous stromal changes and necrosis of bone marrow--a retrospective study of 3 years.
Gupta N; Kumar V; Varma N; Garewal G; Das R; Ahluwalia J; Dash S
Indian J Pathol Microbiol; 2004 Jul; 47(3):351-3. PubMed ID: 16295422
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10).
Visconte V; Tabarroki A; Zhang L; Hasrouni E; Gerace C; Frum R; Ai J; Advani AS; Duong HK; Kalaycio M; Saunthararajah Y; Sekeres MA; His ED; Shetty S; Rogers HJ; Tiu RV
Am J Hematol; 2014 Aug; 89(8):862. PubMed ID: 24796269
[No Abstract] [Full Text] [Related]
17. Significance of bone marrow stromal cells in hematopoiesis and hematological disorders.
Nagao T
Tokai J Exp Clin Med; 1995 Jul; 20(2):121-30. PubMed ID: 8797268
[TBL] [Abstract][Full Text] [Related]
18. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis.
Konoplev S; Hsieh PP; Chang CC; Medeiros LJ; Lin P
Hum Pathol; 2007 Dec; 38(12):1760-3. PubMed ID: 17707884
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicle-mediated remodeling of the bone marrow microenvironment in myeloid malignancies.
Hayashi Y; Nishimura K; Tanaka A; Inoue D
Int J Hematol; 2023 Jun; 117(6):821-829. PubMed ID: 37041345
[TBL] [Abstract][Full Text] [Related]
20. The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies.
Behrmann L; Wellbrock J; Fiedler W
Expert Opin Ther Targets; 2020 May; 24(5):451-462. PubMed ID: 32188313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
